http://www.fpnotebook.com/
Lorazepam
Aka: Lorazepam, Ativan- Indications
- Anxiety Disorder
- Preanesthetic medication
- See Also
- Class
- Medium Acting Benzodiazepine
- Pharmacokinetics
- Half Life: 10-20 hours
- Dosing
- Dose: 0.5 to 2 mg IV, IM or PO every 6 to 8 hours
- Maximum Daily Dose: 4 mg
- Equivalent dosing (for Benzodiazepine Withdrawal)
- Valium = Dose x5.0
- Phenobarbital = Dose x15.0
Lorazepam (C0024002) |
|
|---|---|
| Definition (CHV) | a drug used to treat anxiety |
| Definition (NCI) | A drug that is used to treat anxiety and certain seizure disorders (such as epilepsy), and to prevent nausea and vomiting caused by chemotherapy. It belongs to the families of drugs called antiemetics and benzodiazepines. |
| Definition (CSP) | 7-chloro-5-(2-chlorophenyl)-1, 3-dihydro-3-hydroxy-1,4- benzodiazepin-2-one. |
| Definition (MSH) | A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. |
| Definition (NCI) | A benzodiazepine with anxiolytic, anti-anxiety, anticonvulsant, anti-emetic and sedative properties. Lorazepam enhances the effect of the inhibitory neurotransmitter gamma-aminobutyric acid on the GABA receptors by binding to a site that is distinct from the GABA binding site in the central nervous system. This leads to an increase in chloride channel opening events, a facilitation of chloride ion conductance, membrane hyperpolarization, and eventually inhibition of the transmission of nerve signals, thereby decreasing nervous excitation. |
| Definition (PDQ) | A benzodiazepine with anxiolytic, anti-anxiety, anticonvulsant, anti-emetic and sedative properties. Lorazepam enhances the effect of the inhibitory neurotransmitter gamma-aminobutyric acid on the GABA receptors by binding to a site that is distinct from the GABA binding site in the central nervous system. This leads to an increase in chloride channel opening events, a facilitation of chloride ion conductance, membrane hyperpolarization, and eventually inhibition of the transmission of nerve signals, thereby decreasing nervous excitation. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39757&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39757&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C619" NCI Thesaurus) |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D008140 |
| SnomedCT | 321293002, 334011000, 323084002, 19225000, 387106007 |
| English | Lorazepam, 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-, Lorazepam [anxiolytic], Lorazepam [epilepsy], 7-Chloro-5-(2-chlorophenyl)-1, 3-Dihydro-3-Hydroxy-1,4- Benzodiazepin-2-one, lorazepam, Lorazepam [anaesthesia], Lorazepam [anesthesia], LORAZEPAM, Lorazepam [anxiolytic] (product), Lorazepam [epilepsy] (product), Lorazepam [anesthesia] (product), lorazepam (medication), Lorazepam [Chemical/Ingredient], LORazepam, Lorazepam (product), Lorazepam (substance), Lorazepam [anesthesia] (substance), Lorazepam [anxiolytic] (substance), Lorazepam [epilepsy] (substance) |
| Swedish | Lorazepam |
| Czech | lorazepam |
| Finnish | Loratsepaami |
| Russian | ATIVAN, TAVOR, LORAZEPAM, АТИВАН, ЛОРАЗЕПАМ, ТАВОР |
| Spanish | lorazepam [epilepsia] (producto), lorazepam [anestésico], lorazepam [epilepsia], lorazepam [anestésico] (producto), lorazepam [ansiolítico] (producto), lorazepam [ansiolítico], loracepam (producto), loracepam (sustancia), loracepam, lorazepam (sustancia), lorazepam, Lorazepam |
| Japanese | ロラゼパム |
| Croatian | LORAZEPAM |
| Polish | Lorazepam |
| French | Lorazépam |
| German | Lorazepam |
| Italian | Lorazepam |
| Portuguese | Lorazepam |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Ativan (C0699194) |
|
|---|---|
| Definition (CHV) | brand name of lorazepam |
| Definition (CHV) | brand name of lorazepam |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D008140 |
| English | Ativan [brand name], Baxter Brand of Lorazepam, Lorazepam Baxter Brand, Lorazepam Wyeth Brand, Orfidal Wyeth, Wyeth Brand of Lorazepam, Wyeth, Orfidal, Ativan, Témesta |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |